indefinite complains
Conditions
Interventions
one capsule 3 times a day for 4 weeks
Sponsors
CPCC Co., Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Simplified menopause score has over 26
Exclusion criteria
Exclusion criteria: under treatment by other medicine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| improvement factor of indefinite complains (on 2 weeks and 4 weeks after first administration) | — |
Countries
Japan
Contacts
Public ContactYasuharu Shimizu
Kyushin Pharmaceutical Co., Ltd. Research and development
Outcome results
None listed